Not Yet RecruitingNot Applicable

fullPIERS Model in the Prediction of Adverse Maternal Outcomes in Preeclampsia

Egypt50 participantsStarted 2026-01-01

Plain-language summary

Apredictive formula, fullPIERS (Pre-eclampsia Integrated Estimate of Risk Score), can be used to estimate the risk of suffering an adverse outcome using information obtained within 48 hours of admission with pre-eclampsia. The following information is used, serum creatinine, gestational age, platelet count,

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* Inclusion Criteria Female patients diagnosed with preeclampsia. Gestational age ≥ 20 weeks. Hypertension defined as: Systolic blood pressure ≥ 140 mmHg and/or Diastolic blood pressure ≥ 90 mmHg, measured on at least two occasions more than 4 hours apart. Proteinuria defined as: * 300 mg protein in a 24-hour urine collection or * 0.3 g/dL on urine analysis. Singleton pregnancy. Exclusion Criteria Patients who do not meet the clinical or laboratory diagnostic criteria of preeclampsia.

What they're measuring

Validation of the fullPIERS prediction model for adverse maternal outcomes using logistic regression-derived predicted probabilities

Timeframe: 1year

Evaluate the validity of the fullPIERS model in the prediction of adverse maternal outcomes in women with pre-eclampsia in Sohag Governorate, Egypt.

Timeframe: 1year

Trial details

NCT IDNCT07316140

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-01

View on ClinicalTrials.gov More Preeclampsia trials